Objective: To evaluate lipopolysaccharide (LPS)-induced inhibition of gastric acid secretion. Summary Background Data: Endotoxemia from LPS inhibits gastric acid secretion by an unknown mechanism. Bacterial overgrowth in the stomach caused by decreased acid secretion could be responsible for nosocomial pneumonia developing in critically ill intensive care unit patients. Because acid secretion is via the H/K-ATPase and the effects of LPS on this enzyme are unknown, we hypothesized that LPS causes inhibition of gastric acid secretion by down-regulating the H/K-ATPase Methods: A rat model to study gastric acid secretion was created. Saline or LPS (0.05-20 mg/kg IP) was given for 1 hour, after which basal acid secretion was determined for 1 hour. Pentagastrin (PG; 10 g/kg IV) or saline was then given and gastric acid output collected for another 2 hours Results: LPS dose dependently inhibited basal and PG stimulated acid secretion. LPS increased ␣and ␤-H/K-ATPase subunit mRNA expression (Northern blot) in the absence of PG compared with saline.
B acterial translocation and increased bacterial overgrowth observed in the nonsecreting stomach and the potential for colonization of the tracheal bronchial tree and aspiration remain important considerations as a cause of pneumonia and subsequent multiple organ failure (MOF) in intensive care unit (ICU) patients. The incidence of ICU-acquired pneumonia ranges from 10% to 65% and is associated with significant morbidity, with case fatalities ranging from 13% to 55%. 1, 2 Evidence for causation between gastric bacterial colonization and subsequent development of nosocomial pneumonia in the intensive care unit patient is compelling. 3 Interestingly, the pathogens involved in nosocomial pneumonia are frequently found in gastric aspirates and appear to colonize the stomach prior to the development of clinical pneumonia. 4 -6 Furthermore, acidification of gastric contents has been shown to decrease gut colonization and bacterial translocation. 7 Increased rates of gastric colonization have also been shown when gastric acid secretion is inhibited by histamine-2 receptor antagonists, which are commonly used as prophylactic agents to prevent stress erosive gastritis in ICU patients. 8 -10 However, the mechanism responsible for bacterial overgrowth is unknown. The role of the stomach in the pathogenesis of MOF may be that it serves as a reservoir for the pathogens that may translocate to other organs or cause ventilator associated pneumonias, both of which can exacerbate early MOF or trigger late MOF. 11 Furthermore, because inhibition of gastric acid secretion would predispose the stomach to bacterial overgrowth due to the loss of the natural bactericidal effects of acid, it is important to evaluate the effects of MOF or models that mimic MOF on gastric acid secretion and expression of the acid secreting enzyme, the hydrogen/potassium-adenosinetriphosphatase (H/K-ATPase).
Gastric luminal alkalinization attenuates the natural bactericidal activity of gastric acid and, as a result, creates an environment conducive to bacterial overgrowth. 10 We have previously shown that gastric luminal alkalinization occurs in the setting of endotoxemia. 12 However, the effects of lipopolysaccharide (LPS) on gastric acid secretion were not measured in our model. Furthermore, the effects of LPS on the H/K-ATPase, the enzyme responsible for gastric acid secretion are unknown.
The final common pathway for gastric acid secretion by the parietal cell is the H/K-ATPase, which is composed of a catalytic alpha subunit and a glycoprotein beta subunit. During the nonsecreting state, gastric parietal cells store the H/K-ATPase subunits within intracellular tubulovesicular elements. In response to stimulatory factors, such as pentagastrin, the parietal cell undergoes a conformational change, which leads to fusion of tubulovesicles with the secretory canalicular membrane, recruiting functional H/K-ATPase pumps to an expanded microvillar surface. After fusion, heterodimer assembly of subunits and insertion into the microvilli of the secretory canaliculi occurs, allowing for an increase in gastric acid secretion. [13] [14] [15] Because the H/K-ATPase is responsible for parietal cell secretion of acid, it was our hypothesis that LPS causes inhibition of gastric acid secretion via down regulation of H/K-ATPase expression. To address this hypothesis, we first examined the effects of LPS on basal and pentagastrin stimulated gastric acid secretion. A second experiment assessed the effects of LPS on ␣and ␤-H/K-ATPase subunit expression using Northern blot, Western immunoblot, and immunofluorescence techniques. A fourth study examined the role of the transcription factor nuclear factor-kappa beta (NF-B) in LPS-induced changes in H/K-ATPase expression, as the DNA encoding for the H/K-ATPase ␣2 subunit of the distal colon and renal collecting ducts has binding sites for NF-B. 16 Results of these studies have been published in abstract form. 17, 18 
MATERIALS AND METHODS

Animals and Experimental Model
Female Sprague-Dawley rats weighing approximately 200 g were used in all studies and were housed at constant room temperature with a 12:12-hour light-dark cycle. Rats received their nutritional sources from Harlan Teklad certified Teklad rodent diet (W) product number 8728. All experiments were performed in rats deprived of food for 18 -24 hours but allowed free access to water. The estrus state of the rats was not known. Sample sizes of 5 or more rats were used per study group. On the day of experimentation, all animals were randomly assigned to 1 of several groups. All experiments were approved by the University of Texas at Houston Animal Welfare Committee before studies were conducted.
Effect of LPS on Basal and Pentagastrin-Stimulated Acid Secretion
The first set of experiments was designed to determine what effect LPS had on basal acid secretion. Thus, rats (n Ն 5/group) were given intraperitoneal LPS from Escherichia coli 0111:B4 (0.05-20 mg/kg) whereas control rats received saline. Sixty minutes later, rats were anesthetized with ket-amine (70 mg/kg) and xylazine (6 mg/kg), a tracheostomy performed, and a model to continuously study gastric acid secretion created as previously described. 19 Briefly, 2 silastic catheters were introduced into the stomach via the cervical esophagus and the duodenum for irrigation and collection of gastric effluent. The gastric lumen was irrigated and then perfused continuously with saline (0.9 mL/min) via the esophageal catheter. Gastric effluent was collected every 10 minutes for 60 minutes to determine basal acid secretion. After basal acid secretion was determined, the rats were randomized to receive either the secretagogue pentagastrin (10 g/kg IV) or saline. Acid output was collected continuously for 2 more hours and throughout the experiment and determinations of acid secretion conducted every 10 minutes. The hydrogen output was determined by titration to pH 7.0 with 0.01 M NaOH. Additional rats were given similar doses of LPS and the stomachs assessed for morphologic injury as previously described. 12 The gastric fundus of these rats were not used for immunofluorescence studies; additional experiments were performed as described below. In these studies, alkaline secretion was not measured because the purpose of these LPS dose-response studies was not to show that LPS inhibits acid secretion, but rather to find the lowest dose of LPS to significantly blunt basal and pentagastrin-stimulated acid secretion without causing morphologic injury to the gastric epithelium to study the effects of this dose of LPS on gastric H/K-ATPase expression.
Effect of LPS on H/K-ATPase Expression
Because the 0.5 mg/kg dose of LPS was shown to significantly inhibit gastric acid secretion and not cause morphologic gastric injury (see Results), this dose was used to assess its effects on H/K-ATPase expression, both alone and in the presence of pentagastrin. Accordingly, rats were given either saline or LPS (0.5 mg/kg IP) for 2 or 4.5 hours followed by either saline or pentagastrin (10 g/kg IV) for 30 minutes; the 2 hours LPS time point was the same time point used for acid secretion studies up to the point of maximum pentagastrin-stimulated acid secretion in control rats. Rats were killed, and the fundic mucosa was collected by scraping the mucosa off the underlying muscularis and serosal layers, snap-frozen in liquid nitrogen, and stored at Ϫ70°C prior to Northern and Western blot analysis. In addition, localization of H/K-ATPase subunits was assessed by deconvolution immunofluorescence. To obtain tissue for immunofluorescence studies, rats were given either saline or LPS (0.5 mg/kg IP) for 2 hours followed by either saline or pentagastrin (10 g/kg IV) for 30 minutes, after which rats were anesthetized and full thickness sections of gastric fundic mucosa collected without manipulation.
RNA Extraction and Northern Blot Analysis
Rat gastric mucosal samples were homogenized in 3 mL of the chaotropic reagent RNAzol B (Cinna-Biotecx Laboratories, Houston, TX). Total RNA was isolated from the homogenates by the method of Chomczynski and Sacchi. 19 Samples were quantified by spectrophotometry at 260 nm. Ethidium bromide staining was used for staining to confirm the amounts of loaded RNA and to assess the efficiency of transfer. Isoform-specific cDNAs were generated by polymerase chain reaction (PCR) directed against the ␣and ␤-subunits of the gastric H/K-ATPase as previously described. 20 A rat GAPDH cDNA (nucleotides 469 -984) was also generated by PCR. 21 For Northern analysis, the GAPDH, ␣-subunit, and ␤-subunit specific cDNAs were radiolabeled with 32 P by the random primer method according to the manufacturer's instructions (Prime-a-Gene, Promega, Madison, WI). Fifteen g of total RNA per lane were separated by size on 1% agarose, 2% formaldehyde gels and transferred to nylon membranes (Hybond N, Amersham Corp.). After ultraviolet cross-linking, the blots were visualized under ultraviolet light, hybridized for 2 hours at 68°C in Quick Hyb solution (Stratagene) with probes specific for the ␣-subunit, ␤-subunit, or GAPDH (as an additional control for RNA quality and equality of sample loading and transfer), and washed to a final stringency of 0.1X SSC, 0.1% (s/v) SDS at 60°C. Autoradiographs of the blots were prepared at Ϫ70°C. The blots were sequentially hybridized with the specific probes, with the blots being stripped before proceeding to the next analysis. After each stripping, autoradiographs of the blots were prepared to verify removal of the probe. Intensities of bands on the Northern blots autoradiographs were measured by whole band densitometry software running on a SPARC station IPC (Sun Microsystems, Mt. View, CA) equipped with an image analysis system (Bioimage, Ann Arbor, MI).
Protein Extraction and Western Immunoblot Analysis
For each gastric mucosal tissue sample 1 gram of tissue was added to 10 mL of homogenization buffer (300 mM mannitol, 1 mM Tris-HEPES, 1 mM phenylmethylsulfonyl, 3 mM benzamidine, 1 g/mL soybean trypsin inhibitor; pH 7.5) and homogenized. The samples were centrifuged for 2 minutes at 2500g. The pellet was discarded and MgSO 4 was added to the supernatant to a final concentration of 10 mM MgSO 4 . The samples were intermittently shaken for 15 minutes on ice. The samples were then centrifuged for 12 minutes at 2500g. The supernatant was collected and spun again at 27,000g for 20 minutes. The pellet was collected and resuspended in 5 mL of homogenization buffer containing 10 mM MgSO 4 . The samples were centrifuged at 3100g for 12 minutes and the supernatant collected and spun again at 27,000g for 20 minutes. The pellet, which contains membranous proteins, was collected and resuspended in 10 mM mannitol, 2 mM Tris-HCL; pH 7.5.
The membranous protein extract was then added to sample buffer (125 mM Tris, pH 6.8, 2% SDS, 5% glycerol, 1% ␤-mercaptoethanol, and 0.003% bromphenol blue). Protein concentrations were determined using the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL) prior to the addition of sample buffer. Proteins were separated by SDS (10%)-PAGE, using 5 g of protein per sample. Resultant proteins were electroblotted onto nitrocellulose membranes. Western blotting was performed by usual protocol. Primary antibodies to the ␣and ␤-H/K-ATPase subunits were (1: 10,000) dilutions. Secondary antibody was used at a (1: 10,000) dilution. Immune complexes were visualized with the use of enhanced chemiluminescence detection (Amersham; Arlington Heights, IL). The autoradiograph was then assessed semiquantitatively utilizing computer-assisted densitometry and reported as mean relative densitometric units.
Immunofluorescence
Additional studies were performed for our immunofluorescence studies, and portions of full thickness fundic mucosa were removed intact without any further manipulations. For immunofluorescence microscopy approximately 6 m sections of gastric fundus were obtained from control and LPS and/or pentagastrin-treated animals and cut using Minotone Cryostat (International Equipment Company). Sections were quickly dried onto 18 mm coverslips coated with poly-L-lysine then briefly rinsed in cold phosphate-buffered saline (PBS) prior to 5 minutes fixation in 3.7% formaldehyde (Tousimis Research Corp. Rockville, MD). Sections were rinsed in PBS then inverted onto a drop of blocking solution of approximately 50 L (10% goat serum in PBS) supported by Parafilm (American Can Com; Greenwich, CT). Coverslips were incubated for 30 minutes at 37°C in a humidified cell incubator. After blocking, primary antibodies for the ␣or ␤-H/K-ATPase subunit were added in blocking solution at 1:200 dilution and the coverslips returned to the incubator for 30 minutes. Coverslips were washed in PBS plus 0.05% Tween-20 (TPBS) before affinity-purified goat antimouse-Texas Red and goat antirabbit-Cy-5 was added using a 1:500 dilution in TPBS plus 10% goat serum. Coverslips were returned to a humidified cell incubator for an additional 30 minutes. Coverslips were washed in TPBS prior to post labeling with phalloidin (F-actin), rinsed briefly, then mounted in antifade Elvanol (DuPont; Wilmington, DE). 22 Sections were viewed using an Olympus IX70 inverted microscope (Olympus, Tokyo, Japan). Data sets were acquired using a mercury short arc lamp and were displayed and stored in digital format. Data sets were transferred to a Silicon Graphics workstation for deconvolution. Delta Vision System SoftWoRx (Applied Precision, Isasaquah, WA) was used to deconvolve 0.2 m optical sections before reconstruction. Reconstruction of optical sections was rendered using SoftWoRx.
NF-B Electrophoretic Mobility Shift Assays
To determine NF-B DNA binding activity within the nuclear fractions of gastric mucosa, electrophoretic mobility shift assay was performed. Ten micrograms of nuclear protein extract from each sample was incubated at room temperature for 10 minutes in binding buffer (20% glycerol, 0.25 mg/mL poly (dI-dC) ⅐ poly (dI-dC), 5 mM MgCl 2 , 2.5 mM EDTA, 2.5 mM dithiothreitol, 250 mM NaCl, 50 mM Tris-HCl; pH 7.5). A 32 P end-labeled double-stranded oligonucleotide containing the NF-B binding consensus sequence (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј) was added to the reaction mixture for an additional 20 minutes at room temperature. Reaction products were separated on a nondenaturing 4% poly-acrylamide gel. Blots were dried on a gel dryer and analyzed by exposure to radiographic film.
The specificity of NF-B binding for the putative binding site was established by performing a competition assay where an excess of cold oligonucleotide competitor was preincubated with nuclear extracts from each sample and binding buffer for 10 minutes at room temperature. Because we and others have previously demonstrated that NF-B DNA binding activity in the gastric mucosa is secondary to p50 and p65 subunits, 23, 24 we performed supershift assays with antibodies to p50 and p65 to be certain that other proteins in the extract are not recognizing the DNA binding sequence. The supershift assays were performed by incubating 2 L of each anti-NF-B antibody (p50 and p65) with nuclear extracts in binding buffer for 30 minutes before addition of 32 P-labeled oligonucleotide.
Chemicals
Nitrocellulose filters were purchased from Schleicher Schuell (Keene, NH), and x-ray film (T-MAT) was purchased from Eastman Kodak (Rochester, NY). For Western immunoblots and immunofluorescence a mouse monoclonal anti-␣ subunit and rabbit polyclonal anti-␤ subunit were both from Affinity Bioreagents (Golden, CO). The Enhanced Chemiluminescence System for Western immunoblot analysis was from Amersham (Arlington Heights, IL). For immunofluorescence affinity-purified goat antimouse-Texas Red, goat antirabbit-Cy-5, and Bodipy-phalloidin (F-actin) were purchased from Molecular Probes, Inc. (Eugene, Or). The BCA protein assay was from Pierce. The polyclonal antibodies against p50 and p65 NF-B subunits were obtained from Santa Cruz Biotechnology (Santa Cruz, Ca). Poly (dI-dC) ⅐ poly (dI-dC) was obtained from Amersham Pharmacia Biotech (Piscataway, NJ). All other reagents, including LPS, were molecular biology grade (Sigma Chemical; St. Louis, MO).
Statistics
All values in the figures and text are expressed as means Ϯ SE. Statistical significance was determined using analysis of variance followed by a Scheffé posthoc test. P Ͻ 0.05 was considered to be statistically significant. Figure 1 demonstrates the effects of saline and LPS on basal and pentagastrin stimulated acid secretion. As shown, saline-treated rats had a basal acid secretion of around 0.6 N over the first 60 min. After pentagastrin administration, there was a sharp increase in acid secretion, which peaked after 30 minutes and remained elevated over the next 60 minutes, followed by a return towards baseline. In contrast, LPS dose dependently decreased basal acid secretion and significantly blunted the stimulatory response to pentagastrin. This effect was significant at 0.5, 5, and 20 mg/kg doses (P Ͻ 0.05) and was still present even at a dose as low as 0.05mg/kg. When the gastric epithelium was assessed for morphologic injury, the 0.05 to 0.5 mg/kg doses of LPS did not cause any morphologic injury (not shown) which confirms and extends a prior report by Uehara et al. 25 Moreover, this dose of LPS does not decrease blood flow to the stomach nor cause hemodynamic instability as previously reported. 12
RESULTS
LPS Dose Dependently Inhibits Basal and Pentagastrin Stimulated Gastric Acid Secretion
LPS Does Not Decrease H/K-ATPase Expression
In contrast to our hypothesis that LPS-induced inhibition of gastric acid secretion is caused by a down-regulation of H/K-ATPase expression, we found that 0.5 mg/kg LPS increased mRNA expression of the ␣and ␤-subunits in the absence of pentagastrin (Fig. 2) indicating that H/K-ATPase transcriptional regulation is active following LPS. Interestingly, the increase in H/K-ATPase mRNA after LPS was blocked by administration of pentagastrin. In contrast to H/K-ATPase mRNA, there was no difference in ␣or ␤-sub- unit protein immunoreactivity ( Fig. 3) , indicating that either concomitant translation of protein does not occur or protein has not yet been translated at this time point. To address this we examined protein immunoreactivity at a later time point. As shown in Figure 4 , after 4.5 hours of LPS and 30 minutes saline there is a significant increase in ␣subunit protein immunoreactivity, but not in the ␤ subunit. There is no difference between the other groups.
LPS Causes Parietal Cell Conformational Changes
Although changes in H/K-ATPase enzyme expression may alter gastric acid secretion, conformational changes in the location of the H/K-ATPase within the parietal cell may also cause changes in acid secretion. In resting parietal cells, the enzyme is inactive and usually found within the cytoplasm of the cell attached to tubulovesicle membranes. As previously mentioned, following secretory stimulation of the parietal cell there is a conformational change within the parietal cell wherein the ␣and ␤-subunits are translocated from the tubulovesicles to the microvilli of the secretory canaliculus. [13] [14] [15] This conformational change is necessary for acid production by the proton pump as well as acid output by the parietal cell. Figure 5 is an electron micrograph used with permission by Moody et al, which demonstrates the confor- 
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LPS-Induced H/K-ATPase Expression mational changes associated with stimulation of gastric acid secretion. As shown, in an unstimulated parietal cell the cytoplasm is filled with tubulovesicular elements and mito-chondria with few secretory canaliculi. Also the cell is small and contracted appearing. Upon stimulation (here with histamine), Figure 5 demonstrates a change within the parietal cell wherein the cell becomes rounded and more distended appearing, with loss of tubulovesicles and increased secretory canaliculi. Furthermore, the canaliculi become larger and filled with HCL and water thereby causing the cellular distention. 13 Our immunofluorescence studies demonstrated a similar finding. As shown in Figure 6 , stimulation of gastric acid secretion with pentagastrin alone caused the parietal cells to become large, round, and swollen presumably secondary to increased secretion of HCL and water as compared with unstimulated saline treated controls. In addition, there is considerable immunostaining for both ␣and ␤-subunits that appears to be colocalized at the secretory membrane (purple staining). In contrast, cells treated with LPS alone appeared Immunofluorescence micrograph of gastric parietal cells treated with LPS and/or pentagastrin. Rats were given either saline or LPS (0.5 mg/kg) for 2 hours followed by saline or pentagastrin (10 g/kg) for 30 minutes. Stimulation of gastric acid secretion with pentagastrin alone caused the parietal cells to become enlarged as compared with unstimulated saline-treated controls. In addition, there is considerable immunostaining for both ␣and ␤-subunits that appears to be colocalized at the secretory membrane (purple staining). In contrast, cells treated with LPS alone appeared very thin and contracted with decreased colocalization, as did rats treated with LPS and PG. In both LPS groups, parietal cell morphology was more similar to saline controls than to rats receiving PG alone. Green ϭ F-actin, red ϭ ␣-subunit, blue ϭ ␤-subunit, purple ϭ colocalization of ␣and ␤-subunits. Magnification, ϫ100. very thin and contracted and with less colocalization, as did rats treated with LPS and pentagastrin. In both LPS groups, parietal cell morphology was more similar to saline controls than to rats receiving pentagastrin alone.
LPS Increases NF-B DNA Binding Activity
Because the DNA encoding for the H/K-ATPase ␣2 subunit of the distal colon and renal collecting ducts has binding sites for NF-B 16 we examined the effects of LPS and pentagastrin on gastric mucosal NF-B DNA binding activity. As shown in Figure 7 , LPS caused an increase in NF-B DNA binding activity in the nuclear fraction of gastric mucosa versus saline controls. The increase in DNA binding activity was not blunted by pentagastrin administration as was the increased mRNA expression of the ␣and ␤-subunits suggesting the changes in H/K-ATPase mRNA expression caused by LPS alone and LPS with pentagastrin may not depend upon changes in this transcription factor. Competition studies with unlabelled oligonucleotide probe confirmed the identity of the NF-B binding complex. In addition, following incubation with antibodies to NF-B subunits p50 and p65, a supershift was also seen, confirming that the activated NF-B consisted mainly of p50 subunits and to a lesser extent p65 subunits (not shown) as we and others have previously reported. 23, 24 
DISCUSSION
Although it has been shown that LPS causes inhibition of gastric acid secretion, [25] [26] [27] little is known about the effects of LPS on pentagastrin stimulated acid secretion or on expression of the rate limiting enzyme of acid secretion, the gastric H/K-ATPase. This study demonstrated that LPS dose dependently inhibited both basal and pentagastrin stimulated gastric acid secretion. The inhibitory effects of LPS were present with doses of LPS that have been shown not to cause morphologic gastric injury, result in hemodynamic instability, nor reduce gastric mucosal blood flow. 12 While we hypothesized that LPS would cause a decrease in transcription and translation of H/K-ATPase subunits, this study demonstrated that this was clearly not the case. In fact, LPS increased mRNA for both ␣and ␤-H/K-ATPase subunits in the absence of pentagastrin. Although this increase in mRNA was not accompanied by a change in H/K-ATPase immuno-reactivity at the 2.5 hours time point, at least for the ␣-subunit this appears to be due to translation of mRNA in to protein lagging behind the transcriptional changes, as we have subsequently found that ␣-H/K-ATPase subunit immunoreactivity is increased at 5 hours following LPS. However, we again noted that there was no apparent decrease in H/K-ATPase subunits at either time point.
Perhaps the most noteworthy finding of this study was in the immunofluorescence analysis of the H/K-ATPase subunits after LPS. This study found that pentagastrin caused marked swelling of the parietal cells with colocalized immunostaining for ␣and ␤-subunits appearing to be along the secretory membranes indicative of heterodimer assembly. These findings are consistent with the parietal cell being in a secretory state, which the acid secretion model used in this study confirmed. However, in LPS treated rats, the cells took on a thin and elongated appearance assuming conformational changes associated with control rats that were essentially in a nonsecreting state. This was in sharp contrast to the distended, triangular appearance of the rats receiving pentagastrin without LPS. In addition, immunofluorescent analysis of all rats receiving LPS suggested that the H/K-ATPase subunits were present within the cytosol, not along the membranes with a paucity of colocalized immunostaining. These parietal cell conformational changes characteristic of nonsecreting cells and cytosolic immunostaining were present in all rats receiving LPS whether they also received pentagastrin or not. Taken together, this study suggested that perhaps a novel mechanism exists to explain the ability of LPS to inhibit acid secretion. Specifically, it appears that LPS inhibits acid secretion by preventing insertion of H/K-ATPase subunits into the secretory canaliculus and subsequent heterodimer assembly as opposed to down-regulation of H/K-ATPase expression. To our knowledge, this is the first report to examine the effects of LPS on H/K-ATPase expression. This is also the first study to report that bacterial endotoxin is capable of causing changes in transcription of H/K-ATPase subunits in vivo. Because the genes encoding the gastric H/K-ATPase subunits may contain binding sites for the transcription factor NF-B, 16 we examined the effects of LPS on NF-B binding activity in the presence and in the absence of pentagastrin. This study demonstrated that LPS caused a dramatic increase in NF-B DNA binding activity and that the subunits involved were primarily p50 and p65 as previously reported. 23, 24 However, while pentagastrin significantly blunted the LPS-induced increase in ␣and ␤-H/K-ATPase subunit mRNA, it did not abrogate the LPS-induced increase in NF-B DNA binding activity. These data suggested that the transcriptional changes in H/K-ATPase subunit mRNA following LPS and pentagastrin are most likely not due to changes in NF-B activity. Whether other transcription factors are involved is unknown although recent LPS-Induced H/K-ATPase Expression evidence indicates that activator protein-1 (AP-1) is not responsible either. 18 The increase in H/K-ATPase subunit transcription could be secondary to feedback mechanisms directly related to gastric luminal alkalinization, which is known to cause an increase in H/K-ATPase subunit mRNA. 28 Alternatively, abnormal pump location following secretagogue stimulation, reduced intracellular ATP, alterations in potassium chloride pumps, or alterations in electrochemical gradients within the parietal cell could serve as a stimulus that is recognized by the cell's transcriptional controls. However, whether any of these play a role in our findings with LPS on H/K-ATPase expression is speculative.
Previous studies have demonstrated that gastric acid output is diminished following exposure to noxious stimuli including ionizing radiation, 29 high ambient temperature, 30 gut ischemia/reperfusion injury, 19 and endotoxin. [25] [26] [27] Moreover, LPS was also found to inhibit pentagastrin stimulated acid secretion 26 as did the study utilizing gut ischemia/ reperfusion as the traumatic insult. 19 However, most of these studies employed traumatic insults that also resulted in superficial injury to the gastric epithelium in addition to inhibition of gastric acid secretion, an important observation as even mild damage to the epithelium can result in acid inhibition. 31, 32 A possible mechanism of LPS-induced inhibition of gastric acid secretion may be through NO mediated mechanisms. Martinez-Cuesta et al demonstrated that tetrodotoxin and NG-nitro arginine methyl ester (L-NAME), a nonselective nitric oxide synthase (NOS) inhibitor, restored acid secretion to pentagastrin in endotoxin-treated rats, which suggests that activation of a nonadrenergic noncholinergic neuronal (NANC) pathway involving NO might mediate the acid inhibitory effects of endotoxin. 26 Premaratne et al demonstrated that the neuronal form of NOS is expressed within the parietal cell. Since L-NAME restores acid secretion to pentagastrin in endotoxemic rats, this may suggest also that inhibition of gastric acid secretion by LPS may be through increased neuronal NOS activity either within the parietal cell itself, within the NANC pathway which is mediated also by nNOS, or both. 33 Other studies have also shown that inhibition of gastric acid secretion is in part mediated by increased NO release and appears to be through cyclic GMP and soluble guanylate cyclase pathways. 34 -37 However, how these findings relate to the conformational changes we observed still remains to be seen. Thus, this study not only confirms and extends these other reports, but also indicates that LPS can inhibit gastric acid secretion in doses that do not cause morphologic gastric injury as suggested by Uehara et al. 25 Moreover, this study examined the effects of LPS on the gastric H/K-ATPase, the enzyme responsible for acid secretion.
Critically ill or septic ICU patients frequently have nasogastric tubes placed for associated gastrointestinal ileus, require ventilatory support, and are placed on stress gastritis prophylactic agents that are aimed at reducing gastric acid secretion. Interestingly, a significant number of these patients develop nosocomial pneumonia which carries with it significant morbidity and mortality. 1, 2 Evidence suggests that the stomach participates in the development of nosocomial pneumonia, the principal infection associated with these patients, 3 by serving as a reservoir for bacteria that later colonize the tracheobronchial tree. 4 -7 Because of the strong correlation between bacterial sepsis and MOF, the endotoxin model is frequently used to study organ dysfunction to mimic the clinical scenario. As a result, our findings with LPS may have important clinical implications. Our data suggest that the stomach may contribute to the development of pneumonia by septic insults causing inhibition of acid secretion and a resultant loss of the natural bactericidal effects of gastric acid. Consistent with this notion is the finding that other investigators have shown an increased rate of gastric colonization when gastric acid secretion is inhibited by histamine-2 receptor antagonists. 9, 10 It is also noteworthy that in some of these studies, patients randomized to nonantisecretory agents such as sucralfate also developed gastric luminal alkalinization and colonization, 5, 38, 39 again suggesting that the stomach becomes dysfunctional in this setting. However, other studies challenge the importance of increased gastric colonization with bacterial pathogens on the subsequent development of nosocomial pneumonia. 40, 41 Despite the controversial nature of this clinical problem, it is also interesting to note that acidification of gastric luminal contents is associated with a reduction in ventilator associated pneumonia. Thus, it is our contention that the increased bacterial overgrowth observed in the nonsecreting stomach and the potential for aspiration and colonization of the tracheobronchial tree remain important considerations in these critically ill patients, and the available evidence, including our own suggests, that the stomach participates in this setting by its inability to secrete acid.
In conclusion, this study demonstrated that LPS inhibits basal and pentagastrin stimulated gastric acid secretion. LPSinduced inhibition of gastric secretion was not due to downregulation of H/K-ATPase expression, but appeared to be secondary to an inability of the parietal cell to undergo conformational changes compatible with acid secretion in response to a secretagogue. This study also indicated that the enzyme responsible for acid secretion is under transcriptional regulation following LPS and that these changes in H/K-ATPase subunit mRNA are most likely not due to changes in the transcription factor NF-B. Our findings suggest that critically ill and septic patients in the ICU may be susceptible to the development of nosocomial pneumonia due to inhibition of gastric acid secretion and the subsequent loss of the natural bactericidal effects of gastric acid. Moreover, further studies are needed to assess the clinical efficacy of expensive antisecretory agents to prevent stress gastritis in patients with endotoxemia.
